Tech Company Financing Transactions
Auctus Biologics Funding Round
Auctus Biologics closed a $1.5 million Seed funding round on 9/24/2018. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/24/2018
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2521 US Route 11
LaFayette, NY 13084
USA
LaFayette, NY 13084
USA
Phone
Website
Email Address
Not Recorded
Overview
Auctus Biologics, Inc., a portfolio company of Ichor Therapeutics, is a biotechnology company that creates new therapies using antibody mimetic scaffolds based on RPtag. Founded in 2018, the company is developing next generation biologics and is pursuing targets in extreme anatomical environments like the gut where antibodies cannot currently be used.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kelsey Moody
Browse more venture capital transactions:
Prev: 9/24/2018: F/ELD venture capital transaction
Next: 9/24/2018: Tvardi Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs